Currently, there are 97.44M common shares owned by the public and among those 80.47M shares have been available to trade.
The company’s stock has a 5-day price change of 10.97% and 299.30% over the past three months. HSAI shares are trading 23.66% year to date (YTD), with the 12-month market performance up to 332.66% higher. It has a 12-month low price of $3.52 and touched a high of $17.55 over the same period. HSAI has an average intraday trading volume of 3.30 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 11.11%, 29.06%, and 155.58% respectively.
Institutional ownership of Hesai Group ADR (NASDAQ: HSAI) shares accounts for 13.95% of the company’s 97.44M shares outstanding.
It has a market capitalization of $1.67B and a beta (3y monthly) value of 1.22. The earnings-per-share (ttm) stands at -$0.42. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.04% over the week and 8.64% over the month.
Analysts forecast that Hesai Group ADR (HSAI) will achieve an EPS of 1.42 for the current quarter, 0 for the next quarter and 1.44 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.42 while analysts give the company a high EPS estimate of 1.42. Comparatively, EPS for the current quarter was -0.95 a year ago. Earnings per share for the fiscal year are expected to increase by 74.63%, and 278.91% over the next financial year.
Looking at the support for the HSAI, a number of firms have released research notes about the stock. Goldman stated their Buy rating for the stock in a research note on January 14, 2025, with the firm’s price target at $5.50-$18.40. Morgan Stanley coverage for the Hesai Group ADR (HSAI) stock in a research note released on January 13, 2025 offered a Equal-Weight rating with a price target of $15. Citigroup was of a view on September 26, 2023 that the stock is Buy, while BofA Securities gave the stock Buy rating on September 22, 2023, issuing a price target of $14.80. Goldman on their part issued Neutral rating on August 18, 2023.
